http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108472280-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e071d18fea054bf8d1420d483e78ed1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8073450a491d200d05b09b9beb6f0ec6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a7ebd2ce5ef7e691bd44c48a88a2bfc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
filingDate 2016-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_914ed3c037b3a2cda49d612b0303235a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43ed473ae0ed39f1d52569c819baca0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a57d3aa3822541fa569c40e99eba1b81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3835d9c25f796ebc92dcebd1bbce45e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d32d9e3cd5b1a5f48e582337deeeb639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eefe974c8b155dcb7519bcd79781b416
publicationDate 2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108472280-A
titleOfInvention Compounds and methods for treating or preventing hematological cancers
abstract The present invention includes treatment of genes spanning a range of genetic disorders with a DHODH inhibitor such as 6-fluoro-2-(2'-fluoro-[1,1'-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid. Approaches to subtypes of acute myeloid leukemia patients.
priorityDate 2015-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9813047-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54684141
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499259

Total number of triples: 31.